Provectus Biopharmaceuticals Inc (PVCT)

[vorlon1966]

If memory serves me it is dacarbazine.

http://www.aimatmelanoma.org/en/aim-for-answers/treatment-of-melanoma/fda-approved-drugs-for-melanoma/dtic-dome-dacarbazine.html

The only other drug approved for the indication PV-10 is going after is interferon which kills 15-30 patients per 400. Dacarbazine is the safer of the two. Progression free survival with DTIC is 2.7 months.

http://www.aimatmelanoma.org/en/aim-for-answers/stages-of-melanoma/stage-iii-melanoma/treatment-options-for-stage-iii-melanoma.html

Now I am not certain....but I believe...that any patients in the comparator group that fails with DTIC will be cycled to the treatment arm .